If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
22.10    0.20 (0.91%)
Bid:
22.10
Ask:
23.20
Spread: 1.10 (4.977%)
Market Cap: €122.52b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Preferred securities contingently convertible

28 Aug 2019 07:00

RNS Number : 3308K
Banco Bilbao Vizcaya Argentaria SA
28 August 2019
 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

 

BBVA informs that it intends to launch an offer of securities contingently convertible into ordinary shares of BBVA (the "Securities") with the exclusion of the shareholders' pre-emption right (the "Offer").

 

In accordance with the documentation of the Offer, the Securities are in no event directed towards retail investors and shall not be offered, distributed or sold in Spain or to Spanish tax residents.

 

BBVA will communicate to the market the terms of the Offer once they are determined, where appropriate.

 

 

 

 

 

 

 

Madrid, 27 August 2019

 

 

 

Important information:

There are restrictions with respect to the offering of the Securities in various jurisdictions, including the United Kingdom, Spain, Japan, Singapore, Hong Kong, Canada, Switzerland and the European Economic Area.

This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

This document is not a prospectus and is not an offer or a solicitation to buy, sell, subscribe or exchange any securities issued or to be issued by BBVA. No such offer in relation to the Securities shall be conducted in any jurisdiction in which said offer is not made in conformity with the applicable legislation.

This document is not an offer for sale of securities in the United States and the Securities may not be offered or sold in the United States nor to, on behalf or for the benefit of, any citizen of the United States, as defined in the Regulation S of the US Securities Act of 1933, as amended ("US Securities Act"), unless such Offer is registered or falls under an exception of registration pursuant the US Securities Act.

In relation with the Offer, BBVA has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents BBVA has filed with the SEC for more complete information about BBVA and the Offer. You may obtain these documents for free by visiting the SEC web site at www.sec.gov.

This announcement is not a prospectus but rather is an announcement, and investors should not subscribe for any Securities except on the basis of the information contained in the prospectus, the prospectus supplement and the other documents filed by BBVA with the SEC that are incorporated by reference in the registration statement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFDLLLKVFZBBB
Date   Source Headline
1st Feb 20187:09 amRNS4Q17 Results Presentation
1st Feb 20187:04 amRNS4Q17 Results Report
1st Feb 20187:02 amRNS4Q17 Results Press Release
1st Feb 20187:00 amRNSProposal for payment of dividend
25th Jan 20185:25 pmRNS4Q17 Results Presentation Announcement
10th Jan 20187:00 amRNSAssessment of the shareholding at Telefonica, S.A
28th Dec 20173:26 pmRNSGMTN Programme Supplement to the Offering Circular
27th Dec 201712:59 pmRNSGMTN Programme - Issuer Substitution
27th Dec 201712:42 pmRNSGMTN Programme
21st Dec 20176:29 pmRNSPost Stabilisation Notice
15th Dec 20174:00 pmRNSPublication of approved ECP Information Memorandum
13th Dec 20175:35 pmRNSSREP Capital Requirements 2018
5th Dec 20177:22 amRNSTransmissions and purchases of capital undertaking
4th Dec 201710:47 amRNSFinal Terms 154SNP
29th Nov 20178:13 amRNSSale of real estate business
28th Nov 20177:00 amRNSBinding offer for the acquisition of BBVA Chile
24th Nov 20171:25 pmRNSFinal Terms 153SNP
10th Nov 201712:31 pmRNSFinal Terms Global Medium Term Note Programme
9th Nov 20177:00 amRNSAT1 Issuance for a total nominal amount
8th Nov 201710:52 amRNSPre Stabilisation Notice
7th Nov 20171:10 pmRNSOffer of securities contingently convertible
27th Oct 20174:29 pmRNSGMTN programme Supplement to the Offering Circular
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results press release
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results presentation
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results report
23rd Oct 20175:33 pmRNS3Q17 Results Presentation Announcement
6th Oct 201711:39 amRNSPost Stabilisation Notice BBVA EUR 5yr SNP
28th Sep 20177:55 amRNSHR News Real Estate
28th Sep 20177:00 amRNSDividend October 2017
4th Sep 20174:33 pmRNSFinal Terms 152 Execution version
31st Aug 20177:47 amRNSBBVA Chile News
30th Aug 20178:30 amRNSPre Stabilisation Notice BBVA 5yr EUR SNP
2nd Aug 20177:57 amRNSDBRS upgrades BBVA´s Cédulas Hipotecarias rating
1st Aug 201712:53 pmRNSFinal Supplement 2Q17
27th Jul 20176:04 pmRNS2Q17 Results Report
27th Jul 20175:46 pmRNS2Q17 Results Presentation
27th Jul 20175:30 pmRNS2Q17 Results Press Release
25th Jul 20175:39 pmRNSScope upgrades BBVA's senior unsecured rating
20th Jul 20175:18 pmRNSResults Presentation Announcement
12th Jun 20177:00 amRNSDBRS changes subordinated debt ratings
1st Jun 20177:00 amRNSBoard of Directors changes
25th May 201712:32 pmRNSFinal Terms GMTN151SUB
25th May 201711:26 amRNSFinal Terms
17th May 20177:00 amRNSAT1 Issuance
5th May 201712:55 pmRNSDividend Option
3rd May 201711:58 amRNSsupplemental to the Offering Circular
28th Apr 20178:43 amRNS2016 Audited Financial Statements
27th Apr 20177:00 amRNS1Q17 Results Report
27th Apr 20177:00 amRNS1Q17 Results Presentation
27th Apr 20177:00 amRNS1Q17 Press Release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.